Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Richards

Showing results (51-60 of 736) with videos related to

Pageof 74
Sort By:
European Journal of Heart Failure|June 12, 2021
Urinary peptides in heart failure - the need for care with pees and cuesA Mark Richards, Christopher J Pemberton
Clinical Chemistry|November 17, 2011
Use of natriuretic peptides to guide and monitor heart failure therapyA Mark Richards, Richard W Troughton
European Journal of Heart Failure|September 27, 2017
Harnessing the power of microRNAs as prognostic biomarkers in acute heart failureLee Lee Wong, Arthur Mark Richards
Heart Failure Clinics|March 28, 2007
BNP for clinical monitoring of heart failureRichard W Troughton, A Mark Richards
Heart (British Cardiac Society)|April 3, 2007
Disease monitoring of patients with chronic heart failureM Gary Nicholls, A Mark Richards,
Clinical Science (London, England : 1979)|October 13, 2004
Cardiac natriuretic peptides for cardiac healthMiriam T Rademaker, A Mark Richards
Journal of the American College of Cardiology|March 7, 2009
Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?Suetonia C Palmer, A Mark Richards
Heart (British Cardiac Society)|October 17, 2002
Exercise testing in the assessment of chronic congestive heart failureJohn G Lainchbury, A Mark Richards
Circulation|July 7, 2005
N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?A Mark Richards, Christopher M Frampton
Circulation|May 16, 2018
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJames L Januzzi, A Mark Richards
Pageof 74

Showing results (51-60 of 736) with videos related to

Sort By:
Pageof 74
European Journal of Heart Failure|June 12, 2021
Urinary peptides in heart failure - the need for care with pees and cuesA Mark Richards, Christopher J Pemberton
Clinical Chemistry|November 17, 2011
Use of natriuretic peptides to guide and monitor heart failure therapyA Mark Richards, Richard W Troughton
European Journal of Heart Failure|September 27, 2017
Harnessing the power of microRNAs as prognostic biomarkers in acute heart failureLee Lee Wong, Arthur Mark Richards
Heart Failure Clinics|March 28, 2007
BNP for clinical monitoring of heart failureRichard W Troughton, A Mark Richards
Heart (British Cardiac Society)|April 3, 2007
Disease monitoring of patients with chronic heart failureM Gary Nicholls, A Mark Richards,
Clinical Science (London, England : 1979)|October 13, 2004
Cardiac natriuretic peptides for cardiac healthMiriam T Rademaker, A Mark Richards
Journal of the American College of Cardiology|March 7, 2009
Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?Suetonia C Palmer, A Mark Richards
Heart (British Cardiac Society)|October 17, 2002
Exercise testing in the assessment of chronic congestive heart failureJohn G Lainchbury, A Mark Richards
Circulation|July 7, 2005
N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?A Mark Richards, Christopher M Frampton
Circulation|May 16, 2018
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT StudyJames L Januzzi, A Mark Richards
Pageof 74